v3.26.1
Condensed Statements of Changes in Shareholders’ Equity (Deficit) (Unaudited) - USD ($)
Class B Ordinary Shares
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 $ 958 [1] $ 24,042 $ (26,606) $ (1,606)
Balance (in Shares) at Dec. 31, 2025 [1] 9,583,333      
Net Income (loss) [1] (37,240) (37,240)
Balance at Mar. 31, 2026 $ 958 [1] 24,042 (63,846) (38,846)
Balance (in Shares) at Mar. 31, 2026 [1] 9,583,333      
Balance at Dec. 31, 2025 $ 958 [1] 24,042 (26,606) (1,606)
Balance (in Shares) at Dec. 31, 2025 [1] 9,583,333      
Net Income (loss)       36,791
Balance at Jun. 30, 2026 $ 958 [1] (10,596,979) (10,596,021)
Balance (in Shares) at Jun. 30, 2026 [1] 9,583,333      
Balance at Mar. 31, 2026 $ 958 [1] 24,042 (63,846) (38,846)
Balance (in Shares) at Mar. 31, 2026 [1] 9,583,333      
Sale of Private Placement Warrants [1] 8,468,750 8,468,750
Fair value of Public Warrants at issuance [1] 6,281,875 6,281,875
Compensation expense 245,099 245,099
Allocated value of transaction costs to Private and Public Warrants [1] 407,886 407,886
Accretion for Class A ordinary shares to redemption amount [1] (14,611,880) (10,607,164) (25,219,044)
Net Income (loss) [1] 74,031 74,031
Balance at Jun. 30, 2026 $ 958 [1] $ (10,596,979) $ (10,596,021)
Balance (in Shares) at Jun. 30, 2026 [1] 9,583,333      
[1] Includes up to 1,250,000 Class B ordinary shares that were subject to forfeiture to the extent the underwriters did not exercise the over-allotment option in full or in part (Note 6). On June 4, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As a result, the 1,250,000 Founder Shares are no longer subject to forfeiture.